Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Q2FY22"

33 News Found

Aurobindo Pharma PAT drops to Rs 696.99 cr in Q2FY22
News | November 09, 2021

Aurobindo Pharma PAT drops to Rs 696.99 cr in Q2FY22

The Board of Directors of Aurobindo Pharma have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021


Divis Labs PAT at Rs 606.46 cr. in Q2FY22
News | November 08, 2021

Divis Labs PAT at Rs 606.46 cr. in Q2FY22

Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.


Sun Pharma Q2FY22 PAT jumps to Rs 2088.73 Cr
News | November 03, 2021

Sun Pharma Q2FY22 PAT jumps to Rs 2088.73 Cr

Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.


Caplin Point Labs posts  Q2FY22 PAT at Rs 74.98 Cr
News | November 02, 2021

Caplin Point Labs posts Q2FY22 PAT at Rs 74.98 Cr

The Board of Directors of Caplin Point Laboratories at its meeting have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021


Lyka Labs  Q2FY22 consolidated PAT at Rs. 28.43Cr
News | November 01, 2021

Lyka Labs Q2FY22 consolidated PAT at Rs. 28.43Cr

Lyka Labs has reported consolidated financial results for the period ended September 30, 2021


GlaxoSmithKline posts Q2FY22 consolidated PAT at  Rs. 204.24 Cr
News | November 01, 2021

GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr

GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021


Dr Reddys Laboratories  posts Q2FY22 PAT at Rs 992 Cr
News | November 01, 2021

Dr Reddys Laboratories posts Q2FY22 PAT at Rs 992 Cr

Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021


Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22
News | October 29, 2021

Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22

Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021


Cipla consolidated net profit at Rs 711.36 cr. in Q2FY22
News | October 27, 2021

Cipla consolidated net profit at Rs 711.36 cr. in Q2FY22

Cipla has reported consolidated financial results for the period ended September 30, 2021


Torrent Pharma consolidated PAT at Rs 316 cr. in Q2FY22
News | October 27, 2021

Torrent Pharma consolidated PAT at Rs 316 cr. in Q2FY22

Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021